Results for ''
Largest study of body mass index (BMI) and COVID-19 vaccine effectiveness using the QResearch platform suggests two doses are highly effective against severe disease for people who are...
People with longstanding kidney disease face health issues like heart disease and diabetes that could impact their risk of severe COVID-19 and life expectancy, according to a new study enabled by...
A large-scale clinical trial of a monoclonal antibody treatment for COVID-19 showed that it could reduce deaths by 21 per cent in people who had not mounted a natural antibody response of their own.
Study published in The Lancet Digital Health and supported by the BHF Data Science Centre used health data from 57 million people in England to build the most complete picture of the pandemic in a...
A major success of the UK’s COVID-19 response has been the use of up-to-date, publicly available data – now this approach must be widened to tackle the indirect and long-term effects of the...
Five research teams tell us their top insights from our rapid COVID-19 funding call, established in December 2020 to harness the power of UK data to improve lives in the pandemic and beyond.
Early on in the pandemic, reports started emerging that ethnic minority groups were at greater risk of COVID-19. This project looked at data from healthcare records and linked it to national...
Analysis of community cohort studies linked to national testing data to understand how COVID-19 spreads at home, work, school and other public places and if this is affected by age, ethnic...
The pandemic changed the way we work. This project looked to understand how the pandemic impacted the working lives of women and men differently, focusing on job loss, precarious work and...
